4nfe: Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4nfe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4nfe OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4nfe RCSB], [http://www.ebi.ac.uk/pdbsum/4nfe PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4nfe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4nfe OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4nfe RCSB], [http://www.ebi.ac.uk/pdbsum/4nfe PDBsum]</span></td></tr> | ||
</table> | </table> | ||
== Function == | |||
[[http://www.uniprot.org/uniprot/KLK2_HUMAN KLK2_HUMAN]] Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin. | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 21: | Line 23: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Tissue kallikrein]] | [[Category: Tissue kallikrein]] | ||
[[Category: Brandstetter, H | [[Category: Brandstetter, H]] | ||
[[Category: Goettig, P | [[Category: Goettig, P]] | ||
[[Category: Magdolen, V | [[Category: Magdolen, V]] | ||
[[Category: Skala, W | [[Category: Skala, W]] | ||
[[Category: Chymotrypsin-like protease]] | [[Category: Chymotrypsin-like protease]] | ||
[[Category: Extracellular]] | [[Category: Extracellular]] | ||
[[Category: Hydrolase]] | [[Category: Hydrolase]] | ||
[[Category: Zinc binding]] | [[Category: Zinc binding]] |
Revision as of 19:18, 24 December 2014
Structural highlights
Function[KLK2_HUMAN] Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin. Publication Abstract from PubMedHuman kallikrein-related peptidase (KLK) 2 is a tryptic serine protease predominantly expressed in prostatic tissue and secreted into prostatic fluid, a major component of seminal fluid. Most likely, it activates and complements chymotryptic KLK3 (prostate-specific antigen) in cleaving seminal clotting proteins, resulting in sperm liquefaction. KLK2 belongs to the "classical" KLKs 1-3, which share an extended 99- or kallikrein loop near their non-primed substrate binding site. Here, we report the 1.9 A crystal structures of two KLK2-small molecule inhibitor complexes. In both structures, discontinuous electron density for the 99-loop indicates that this loop is largely disordered. We provide evidence that the 99-loop is responsible for two biochemical peculiarities of KLK2, i.e. reversible inhibition by micromolar Zn2+ concentrations and permanent inactivation by autocatalytic cleavage. Indeed, several 99-loop mutants of KLK2 displayed an altered susceptibility to Zn2+, which located the Zn2+ binding site at the 99-loop/active site interface. In addition, we identified an autolysis site between residues 95e and 95f in the 99-loop, whose elimination prevented the mature enzyme from limited autolysis and irreversible inactivation. An exhaustive comparison of KLK2 with related structures revealed that in the KLK family, the 99-, 148- and 220-loop exist in open and closed conformations, allowing or preventing substrate access, which extends the concept of conformational selection in trypsin-related proteases. Taken together, our novel biochemical and structural data on KLK2 identify its 99-loop as a key player in activity regulation. Structure-Function Analyses of Human Kallikrein-Related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity.,Skala W, Utzschneider DT, Magdolen V, Debela M, Guo S, Craik CS, Brandstetter H, Goettig P J Biol Chem. 2014 Oct 16. pii: jbc.M114.598201. PMID:25326387[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
|